Search
for
Sort by
Research 931–960 of 1000+
- Management of Advanced Prostate Cancer Undergoing Major Shift
- Urological Oncology: Prostate Cancer
- How not to detect prostate cancer
- Effects of the androgen receptor overexpression in prostate cancer
- TRAIL sensitization of PC3 prostate cancer cells by doxorubicin can be blocked by the anti-oxidant N-acetyl-cysteine or by the iron chelator deferoxamine
- Doxetaxel: new indication. Prostate cancer: a few more weeks.
- Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms
- Androgen biosynthetic pathways in the human prostate
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- New Methods of Endocrine Management of Prostatic Cancer
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- Evaluation of Sex Hormone Levels in Benign Prostatic Hyperplasia Patients Treated with 5 Alpha-Reductase Inhibitor (Finasteride) in Amara city/Iraq
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta.
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- Medico-Surgical Therapeutic Management of Benign Prostatic Hyperplasia
- Topical Application of Thermobalancing Therapy Enabled by Therapeutic Device Treats Enlarged Prostate and Improves Men's Quality of Life; New Opportunity in BPH Treatment
- UP-02.009 Clinical Significance of Intravesical Prostatic Protrusion/Prostate Volume
- Update on medical management of benign prostatic hyperplasia
- Estudio clínico-patológico sobre el cáncer de próstata incidental en pacientes intervenidos bajo el supuesto diagnóstico de HBP sintomática
- Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study
- Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use
- Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase
- Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer
- Androgen receptor-mediated gene activation in prostate cancer cells
- Faculty Opinions recommendation of Screening for prostate cancer.
- 1452 DETECTION RATE OF CLINICALLY INSIGNIFICANT PROSTATE CANCER INCREASES WITH REPEATING PROSTATE BIOPSIES